The following Financial Services guidance note provides comprehensive and up to date legal information covering:
The European Market Infrastructure Regulation (EU) 648/2012 (EMIR) is the principal EU measure regulating the over the counter (OTC) derivatives market. Its key elements are:
a requirement to clear standardised OTC derivatives through a central counterparty (CCP)—see Clearing obligation below
a requirement to report derivative contracts to a trade repository (TR)—see Trade reporting obligation below
margin requirements for non-centrally cleared OTC derivatives—Margin requirements below, and
additional risk mitigation requirements for uncleared trades, including timely confirmation, portfolio reconciliation, portfolio compression and dispute resolution—see Additional risk mitigation requirements below
For an overview of the technical standards (TS) adopted by the European Commission, guidelines published by the European Securities and Markets Authority (ESMA), and related consultations, final reports and technical advice, see Practice Note: European Market Infrastructure Regulation (EMIR)—level 2 and level 3 measures.
This Practice Note describes the requirements of EMIR as amended, where applicable, by EMIR REFIT (Regulation (EU) 2019/834) amending EMIR as regards the clearing obligation, the suspension of the clearing obligation, the reporting requirements, the risk-mitigation techniques for OTC derivative contracts not cleared by a CCP, the registration and supervision of TRs and the requirements for TRs), which has effect from 17 June 2019.
EMIR 2.2 (Regulation (EU) 2019/2099 amending EMIR as regards the procedures and authorities
**excludes LexisPSL Practice Compliance, Practice Management and Risk and Compliance. To discuss trialling these LexisPSL services please email customer service via our online form. Free trials are only available to individuals based in the UK. We may terminate this trial at any time or decide not to give a trial, for any reason. Trial includes one question to LexisAsk during the length of the trial.
To view the latest version of this document and thousands of others like it, sign-in to LexisPSL or register for a free trial.
Existing user? Sign-in
Take a free trial
Take a free trial
0330 161 1234